Marko Repic joined MC Toxicology Consulting in 2015 as a junior consultant. He supports the non-clinical development of small molecules and ATMPs with focus on cancer and gene therapies for rare genetic disorders. Marko contributes to preparation of various regulatory documents, such as Briefing Documents, non-clinical sections of IBs and INDs. He is a molecular biologist by training, with a core expertise in areas of cancer, mammalian neural development and stem cell biology. He studied molecular biology at the Comenius University in Bratislava and completed his doctoral and postdoctoral research at IMBA - Institute of Molecular Biotechnology in Vienna.

 Toxicology, Pharmacology, and Pharmacokinetics